Reversal of CPT-11 resistance of lung cancer cells by adenovirus- mediated gene transfer of the human carboxylesterase cDNA

Akira Kojima, Neil R. Hackett, Ronald Crystal

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

To evaluate the concept that transfer of the human carboxylesterase (CE) gene will overcome the drug resistance of a solid tumor to CPT-11 (irinotecan), we used an adenovirus vector (AdCMV.CE) carrying human CE cDNA to infect CPT-11-resistant A549 human adenocarcinoma cells (A549/CPT) in vitro and in vivo and evaluated cell growth over time. The A549/CPT cells, selected by stepwise and continuous exposure of parental A549 cells to CPT- 11 over 10 months, had a 6-fold resistance to CPT-11 and 42% CE activity in comparison with parental A549 cells. AdCMV.CE infection resulted in an increase in functional CE protein in resistant cells in vitro that was sufficient to convert CPT-11 to its active metabolite, SN-38, and effectively suppressed resistant cell growth in vitro in the presence of CPT-11. When AdCMV.CE was directly injected into established s.c. resistant A549-based tumors in nude mice receiving CPT-11, there was a 1.8-fold reduction in tumor size at day 20 compared to that of controls (P < 0.05). These observations suggest that adenovirus-mediated gene transfer of the human CE gene and concomitant administration of CPT-11 may have potential as a strategy for local control of acquired CPT-11 resistance of solid tumors.

Original languageEnglish
Pages (from-to)4368-4374
Number of pages7
JournalCancer Research
Volume58
Issue number19
Publication statusPublished - 1 Oct 1998
Externally publishedYes

Fingerprint

irinotecan
Carboxylesterase
Adenoviridae
Lung Neoplasms
Complementary DNA
Genes
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Reversal of CPT-11 resistance of lung cancer cells by adenovirus- mediated gene transfer of the human carboxylesterase cDNA. / Kojima, Akira; Hackett, Neil R.; Crystal, Ronald.

In: Cancer Research, Vol. 58, No. 19, 01.10.1998, p. 4368-4374.

Research output: Contribution to journalArticle

@article{5ec13a8095b347ceab5c6fb9899d9349,
title = "Reversal of CPT-11 resistance of lung cancer cells by adenovirus- mediated gene transfer of the human carboxylesterase cDNA",
abstract = "To evaluate the concept that transfer of the human carboxylesterase (CE) gene will overcome the drug resistance of a solid tumor to CPT-11 (irinotecan), we used an adenovirus vector (AdCMV.CE) carrying human CE cDNA to infect CPT-11-resistant A549 human adenocarcinoma cells (A549/CPT) in vitro and in vivo and evaluated cell growth over time. The A549/CPT cells, selected by stepwise and continuous exposure of parental A549 cells to CPT- 11 over 10 months, had a 6-fold resistance to CPT-11 and 42{\%} CE activity in comparison with parental A549 cells. AdCMV.CE infection resulted in an increase in functional CE protein in resistant cells in vitro that was sufficient to convert CPT-11 to its active metabolite, SN-38, and effectively suppressed resistant cell growth in vitro in the presence of CPT-11. When AdCMV.CE was directly injected into established s.c. resistant A549-based tumors in nude mice receiving CPT-11, there was a 1.8-fold reduction in tumor size at day 20 compared to that of controls (P < 0.05). These observations suggest that adenovirus-mediated gene transfer of the human CE gene and concomitant administration of CPT-11 may have potential as a strategy for local control of acquired CPT-11 resistance of solid tumors.",
author = "Akira Kojima and Hackett, {Neil R.} and Ronald Crystal",
year = "1998",
month = "10",
day = "1",
language = "English",
volume = "58",
pages = "4368--4374",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Reversal of CPT-11 resistance of lung cancer cells by adenovirus- mediated gene transfer of the human carboxylesterase cDNA

AU - Kojima, Akira

AU - Hackett, Neil R.

AU - Crystal, Ronald

PY - 1998/10/1

Y1 - 1998/10/1

N2 - To evaluate the concept that transfer of the human carboxylesterase (CE) gene will overcome the drug resistance of a solid tumor to CPT-11 (irinotecan), we used an adenovirus vector (AdCMV.CE) carrying human CE cDNA to infect CPT-11-resistant A549 human adenocarcinoma cells (A549/CPT) in vitro and in vivo and evaluated cell growth over time. The A549/CPT cells, selected by stepwise and continuous exposure of parental A549 cells to CPT- 11 over 10 months, had a 6-fold resistance to CPT-11 and 42% CE activity in comparison with parental A549 cells. AdCMV.CE infection resulted in an increase in functional CE protein in resistant cells in vitro that was sufficient to convert CPT-11 to its active metabolite, SN-38, and effectively suppressed resistant cell growth in vitro in the presence of CPT-11. When AdCMV.CE was directly injected into established s.c. resistant A549-based tumors in nude mice receiving CPT-11, there was a 1.8-fold reduction in tumor size at day 20 compared to that of controls (P < 0.05). These observations suggest that adenovirus-mediated gene transfer of the human CE gene and concomitant administration of CPT-11 may have potential as a strategy for local control of acquired CPT-11 resistance of solid tumors.

AB - To evaluate the concept that transfer of the human carboxylesterase (CE) gene will overcome the drug resistance of a solid tumor to CPT-11 (irinotecan), we used an adenovirus vector (AdCMV.CE) carrying human CE cDNA to infect CPT-11-resistant A549 human adenocarcinoma cells (A549/CPT) in vitro and in vivo and evaluated cell growth over time. The A549/CPT cells, selected by stepwise and continuous exposure of parental A549 cells to CPT- 11 over 10 months, had a 6-fold resistance to CPT-11 and 42% CE activity in comparison with parental A549 cells. AdCMV.CE infection resulted in an increase in functional CE protein in resistant cells in vitro that was sufficient to convert CPT-11 to its active metabolite, SN-38, and effectively suppressed resistant cell growth in vitro in the presence of CPT-11. When AdCMV.CE was directly injected into established s.c. resistant A549-based tumors in nude mice receiving CPT-11, there was a 1.8-fold reduction in tumor size at day 20 compared to that of controls (P < 0.05). These observations suggest that adenovirus-mediated gene transfer of the human CE gene and concomitant administration of CPT-11 may have potential as a strategy for local control of acquired CPT-11 resistance of solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=0032188839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032188839&partnerID=8YFLogxK

M3 - Article

C2 - 9766666

AN - SCOPUS:0032188839

VL - 58

SP - 4368

EP - 4374

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 19

ER -